Literature DB >> 30277599

CCL17 exerts a neuroimmune modulatory function and is expressed in hippocampal neurons.

Lorenz Fülle1, Nina Offermann1, Jan Niklas Hansen2, Björn Breithausen3, Anna Belen Erazo1, Oliver Schanz1, Luca Radau1, Fabian Gondorf1, Konrad Knöpper1, Judith Alferink4, Zeinab Abdullah5, Harald Neumann6, Heike Weighardt1, Christian Henneberger3,7,8, Annett Halle2,8, Irmgard Förster1.   

Abstract

Chemokines are important signaling molecules in the immune and nervous system. Using a fluorescence reporter mouse model, we demonstrate that the chemokine CCL17, a ligand of the chemokine receptor CCR4, is produced in the murine brain, particularly in a subset of hippocampal CA1 neurons. We found that basal expression of Ccl17 in hippocampal neurons was strongly enhanced by peripheral challenge with lipopolysaccharide (LPS). LPS-mediated induction of Ccl17 in the hippocampus was dependent on local tumor necrosis factor (TNF) signaling, whereas upregulation of Ccl22 required granulocyte-macrophage colony-stimulating factor (GM-CSF). CCL17 deficiency resulted in a diminished microglia density under homeostatic and inflammatory conditions. Further, microglia from naïve Ccl17-deficient mice possessed a reduced cellular volume and a more polarized process tree as assessed by computer-assisted imaging analysis. Regarding the overall branching, cell surface area, and total tree length, the morphology of microglia from naïve Ccl17-deficient mice resembled that of microglia from wild-type mice after LPS stimulation. In line, electrophysiological recordings indicated that CCL17 downmodulates basal synaptic transmission at CA3-CA1 Schaffer collaterals in acute slices from naïve but not LPS-treated animals. Taken together, our data identify CCL17 as a homeostatic and inducible neuromodulatory chemokine affecting the presence and morphology of microglia and synaptic transmission in the hippocampus.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  CCL17; CCL22; LPS-induced inflammation; hippocampus; microglia morphology; neuromodulatory chemokines; neuron-glia cross-talk

Mesh:

Substances:

Year:  2018        PMID: 30277599     DOI: 10.1002/glia.23507

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  11 in total

1.  CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure.

Authors:  Yang Zhang; Yicong Ye; Xiaoqiang Tang; Hui Wang; Toshiko Tanaka; Ran Tian; Xufei Yang; Lun Wang; Ying Xiao; Xiaomin Hu; Ye Jin; Haiyu Pang; Tian Du; Honghong Liu; Lihong Sun; Shuo Xiao; Ruijia Dong; Luigi Ferrucci; Zhuang Tian; Shuyang Zhang
Journal:  J Exp Med       Date:  2022-06-10       Impact factor: 17.579

2.  Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.

Authors:  Lisi Flores-Aguilar; M Florencia Iulita; Olivia Kovecses; Maria D Torres; Sarah M Levi; Yian Zhang; Manor Askenazi; Thomas Wisniewski; Jorge Busciglio; A Claudio Cuello
Journal:  Brain       Date:  2020-12-01       Impact factor: 13.501

3.  Recombinant CCL17 Enhances Hematoma Resolution and Activation of CCR4/ERK/Nrf2/CD163 Signaling Pathway After Intracerebral Hemorrhage in Mice.

Authors:  Shuixiang Deng; Prativa Sherchan; Peng Jin; Lei Huang; Zachary Travis; John H Zhang; Ye Gong; Jiping Tang
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

4.  Recombinant CCL17-dependent CCR4 activation alleviates neuroinflammation and neuronal apoptosis through the PI3K/AKT/Foxo1 signaling pathway after ICH in mice.

Authors:  Shuixiang Deng; Peng Jin; Prativa Sherchan; Shengpeng Liu; Yuhui Cui; Lei Huang; John H Zhang; Ye Gong; Jiping Tang
Journal:  J Neuroinflammation       Date:  2021-03-01       Impact factor: 8.322

Review 5.  Dendritic Cells: Neglected Modulators of Peripheral Immune Responses and Neuroinflammation in Mood Disorders?

Authors:  Rafael Leite Dantas; Jana Freff; Oliver Ambrée; Eva C Beins; Andreas J Forstner; Udo Dannlowski; Bernhard T Baune; Stefanie Scheu; Judith Alferink
Journal:  Cells       Date:  2021-04-19       Impact factor: 6.600

6.  CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain.

Authors:  Joanna Bogacka; Katarzyna Ciapała; Katarzyna Pawlik; Klaudia Kwiatkowski; Jan Dobrogowski; Anna Przeklasa-Muszynska; Joanna Mika
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

7.  Modelling Lyssavirus Infections in Human Stem Cell-Derived Neural Cultures.

Authors:  Vinod Sundaramoorthy; Nathan Godde; Ryan J Farr; Diane Green; John M Haynes; John Bingham; Carmel M O'Brien; Megan Dearnley
Journal:  Viruses       Date:  2020-03-25       Impact factor: 5.048

8.  Elevated serum chemokine CCL22 levels in first-episode psychosis: associations with symptoms, peripheral immune state and in vivo brain glial cell function.

Authors:  Heikki Laurikainen; Arja Vuorela; Anna Toivonen; Linnea Reinert-Hartwall; Kalevi Trontti; Maija Lindgren; Jaakko Keinänen; Teemu Mäntylä; Janina Paju; Tuula Ilonen; Reetta-Liina Armio; Maija Walta; Jouni Tuisku; Semi Helin; Päivi Marjamäki; Iiris Hovatta; Sebastian Therman; Outi Vaarala; Outi Linnaranta; Tuula Kieseppä; Raimo K R Salokangas; Jarno Honkanen; Jarmo Hietala; Jaana Suvisaari
Journal:  Transl Psychiatry       Date:  2020-03-16       Impact factor: 6.222

9.  CCL17-expressing dendritic cells in the intestine are preferentially infected by Salmonella but CCL17 plays a redundant role in systemic dissemination.

Authors:  Anna B Erazo; Nancy Wang; Lena Standke; Adrian D Semeniuk; Lorenz Fülle; Sevgi C Cengiz; Manja Thiem; Heike Weighardt; Richard A Strugnell; Irmgard Förster
Journal:  Immun Inflamm Dis       Date:  2021-05-04

10.  ENT-A010, a Novel Steroid Derivative, Displays Neuroprotective Functions and Modulates Microglial Responses.

Authors:  Canelif Yilmaz; Thanasis Rogdakis; Alessia Latorrata; Evangelia Thanou; Eleftheria Karadima; Eleni Papadimitriou; Eleni Siapi; Ka Wan Li; Theodora Katsila; Theodora Calogeropoulou; Ioannis Charalampopoulos; Vasileia Ismini Alexaki
Journal:  Biomolecules       Date:  2022-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.